Your browser doesn't support javascript.
loading
Alternating bortezomib-dexamethasone and lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma aged over 75 years.
Yokoyama, Akihiro; Kada, Akiko; Kagoo, Toshiya; Hidaka, Michihiro; Iida, Hiroatsu; Miyata, Yasuhiko; Saito, Akiko M; Sawamura, Morio; Komeno, Takuya; Sunami, Kazutaka; Takezako, Naoki; Nagai, Hirokazu.
Afiliación
  • Yokoyama A; Division of Hematology, Department of Internal Medicine, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Kada A; Division of Transfusion Medicine, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Kagoo T; Department of Clinical Trials and Research, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Hidaka M; Division of Hematology, Department of Internal Medicine, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Iida H; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
  • Miyata Y; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Saito AM; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Sawamura M; Department of Clinical Trials and Research, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Komeno T; Department of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan.
  • Sunami K; Department of Hematology, National Hospital Organization Mito Medical Center, Ibaraki, Japan.
  • Takezako N; Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Nagai H; Department of Hematology, National Hospital Organization Disaster Medical Center of Japan, Tachikawa, Japan.
Nagoya J Med Sci ; 84(1): 80-90, 2022 Feb.
Article en En | MEDLINE | ID: mdl-35392014

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Aged80 / Humans Idioma: En Revista: Nagoya J Med Sci Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Aged80 / Humans Idioma: En Revista: Nagoya J Med Sci Año: 2022 Tipo del documento: Article País de afiliación: Japón